Amino-aryl-benzamide compounds and methods of use thereof
申请人:HEPANOVA, INC.
公开号:US11000491B2
公开(公告)日:2021-05-11
A method for the treatment and/or reduction of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) is disclosed. The method uses active amino-aryl-benzamide compounds and methods for the preparation thereof.
AMINO-ARYL-BENZAMIDE COMPOUNDS AND METHODS OF USE THEREOF
申请人:HEPANOVA, INC.
公开号:US20210338610A1
公开(公告)日:2021-11-04
A method for the treatment and/or reduction of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) is disclosed. The method uses active amino-aryl-benzamide compounds and methods for the preparation thereof.